Adimab, LLC
SEC CIK 1545672 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | 10%, See Remarks | 21.69M | — | $19.75M | 3 | 2021-08-10 | 2024-01-19 |
Most active insiders at IVVD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Andersen Jill | CLO, Sec | — | $158.5K |
| 2 | MCLAUGHLIN KEVIN F | Dir | $125.0K | — |
| 3 | Lee Timothy Edward | Chief Commercial Off | — | $95.1K |
| 4 | Green Julie | CHRO | — | $95.1K |
| 5 | Duke William E. | CFO | — | $95.1K |
| 6 | Allen Robert D. III | CSO | — | $87.9K |
Adimab, LLC made no open-market trades at IVVD in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-22 | 2024-01-19 | IVVD | Invivyd, Inc. | Adimab, LLC | 10% | S - Sale | $3.95 | -5.00M | 21.69M | -19% | -$19.75M | |
| 2022-04-01 | 2022-03-03 | IVVD | Invivyd, Inc. | Adimab, LLC | 10%, See Remarks | J - Other | — | -1.16M | 26.69M | -4% | — | |
| D | 2021-08-12 | 2021-08-10 | IVVD | Invivyd, Inc. | Adimab, LLC | 10% | C - Cnv Deriv | — | +25.86M | 27.85M | +1,303% | — |
Purchase Sale Sale after option exercise All abbreviations